FNBOH
UTHR icon

First National Bank of Hutchinson’s United Therapeutics UTHR Stock Holding History

First National Bank of Hutchinson’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,553
Closed -$787K – 94
2025
Q1 		$787K Sell
2,553
-21
-0.8% -$7.2K 0.52% 39
2024
Q4 		$908K Buy
2,574
+93
+4% +$34.2K 0.55% 40
2024
Q3 		$889K Buy
2,481
+785
+46% +$265K 0.57% 43
2024
Q2 		$540K Buy
+1,696
New +$449K 0.35% 67

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

First National Bank of Hutchinson's UTHR Position: Q2 2025 in Review

First National Bank of Hutchinson sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 2,553 shares — an estimated $787K sold.

First National Bank of Hutchinson first reported a position in UTHR in Q2 2024 and held it in 4 quarters. The position peaked at $908K in Q4 2024. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • First National Bank of Hutchinson reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • First National Bank of Hutchinson sold 2,553 United Therapeutics shares in Q2 2025, an estimated $787K.
  • First National Bank of Hutchinson first reported a position in United Therapeutics in Q2 2024 and held it in 4 quarters.
  • First National Bank of Hutchinson's United Therapeutics position peaked at $908K in Q4 2024.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on First National Bank of Hutchinson's 13F filing for Q2 2025, filed 29 Jul 2025.